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In obesity, adipocytes distant from vasculature
become hypoxic and dysfunctional. This hypoxic
response is mediated by hypoxia-inducible factors
(Hif1a, Hif2a, and Hif3a) and their obligate partner,
Hif1b (Arnt). We show that mice lacking Hif1b in fat
(FH1bKO) are lean, exhibit reduced adipocyte size,
and are protected from age- and diet-induced
glucose intolerance. There is also reduced Vegf and
vascular permeability in FH1bKO fat, but diet-
induced inflammation and fibrosis is unchanged.
Adipocytes from FH1bKO mice have reduced
glucose uptake due to decreased Glut1 and Glut4,
which is mirrored in 3T3-L1 adipocytes with Hif1b
knockdown. Hif1b knockdown cells also fail to
respond appropriately to hypoxia with reduced
cellular respiration and reduced mitochondrial gene
expression. Some, but not all, of these effects are re-
produced by Hif1a knockdown. Thus, Hif1b/Arnt
regulates glucose uptake, mitochondrial gene
expression, and vascular permeability to control
adipose mass and function, providing a target for
obesity therapy.
INTRODUCTION
Over the past 30 years, the prevalence of obesity dramatically
increased along with associated diseases, including type 2 dia-
betes, coronary heart disease, hypertension, hepatosteotosis,
and even cancer (Bray, 2004). With obesity, adipocytes distant
from the vasculature become hypoxic, and this has been
proposed to be an important contributor to adipose tissue
dysfunction leading to insulin resistance and diabetes (Trayhurn
and Wood, 2004).
The main sensor and mediator of the hypoxic response is the
Hif family of proteins. Hifs are basic helix-loop–helix transcription
factors that function as a and b heterodimers. Hif proteins are
essential for normal development, and whole-body Hif1a and
Hif2a knockout mice die in midgestation with developmental
defects of the cardiovascular system (Iyer et al., 1998; Scortega-
gna et al., 2003; Compernolle et al., 2002). All Hif-a isoforms
require Hif1b as an obligate heterodimeric partner to functionCellas transcriptional regulators. Hif1b is also known as Arnt (the
aryl hydrocarbon receptor Ahr nuclear translocator) because it
acts as the transcriptional partner for the aryl hydrocarbon
receptor (Ahr) and single-minded gene1 (Sim1) (Swanson et al.,
1995). Therefore, ablation of Hif1b results in an absence of
Hif- and Ahr-induced signaling. Whole-body Hif1b knockout
mice die at midgestation due to numerous developmental
defects (Maltepe et al., 1997). Ablation ofHif1b in the liver is suffi-
cient to lead to lack of target gene induction of Hif1a, Hif2a, and
Ahr (Tomita et al., 2000; Rankin et al., 2005). In addition, we have
previously demonstrated that type 2 diabetes subjects have
lower Hif1b levels in both the b cells and liver, contributing to
impaired glucose-stimulated insulin secretion and aberrant
expression of key lipogenic and gluconeogenic enzymes (Gun-
ton et al., 2005; Wang et al., 2009).
Recently, all Hif-a subunits have been shown to have roles
in adipocyte biology. Overexpression of constitutively active
Hif1a in mouse adipose tissue induces fibrosis and insulin resis-
tance (Halberg et al., 2009). Conversely, expression of a domi-
nant-negativeHif1a in adipose tissue perturbsbrown fat function,
leading to increased obesity and insulin resistance (Zhang et al.,
2010). BothHif2a andHif3a have been shown to have roles in adi-
pogenesis and adipocyte function (Peng et al., 2000; Hatanaka
et al., 2009). Finally, insulin resistance is observed in 3T3-L1
adipocytesoverexpressingHif1aorHif2a (Regazzetti et al., 2009).
In the present study, we have evaluated the role of the Hif
transcriptional system by creating a mouse lacking Hif1b (Arnt)
in adipose tissue. We find that these mice are resistant to age-
and diet-induced obesity and its associated glucose intoler-
ance. This occurs through effects on varied processes, including
effects on adipocyte cell size, glucose uptake, control of vascular
permeability, and regulation of the hypoxic response. The effects
are mediated in part through the actions of Hif1a and involve
both cell-autonomous and cell-nonautonomous changes medi-
ated via Vegf. Taken together, these data demonstrate a critical
role for Hif1b in the control of adipose tissue mass and function.RESULTS
aP2-Cre Effectively Ablates Hif1b from Adipocytes
We created mice with an ablation of Hif1b in adipocytes by
breeding aP2-Cre transgenic mice and mice carrying a Hif1b
allele with loxP sites surrounding exon 5 (Abel et al., 2001).
aP2-Cre; Hif1b f/f (termed fat-specific Hif1b knockout [FH1bKO])
mice were born at the expected ratio and exhibited no overtMetabolism 14, 491–503, October 5, 2011 ª2011 Elsevier Inc. 491
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Figure 1. aP2-Cre Effectively Ablates Hif1b in Adipocytes
(A) Expression level of Hif1b mRNA was compared using quantitative real-time PCR (qPCR) between adipocytes isolated from the subcutaneous fat (SCF),
perigonadal fat (PGF), andwhole brown adipose tissue (BAT) in female control and FH1bKOmice.Mice were 6–8weeks of age. Data are shown asmean ± SEMof
five samples.
(B) Western blot ofHif1b from isolated PGF adipocytes of control and FH1bKOmice at 12 weeks of age. Actin served as a loading control. Data are representative
of four samples.
(C) Expression level of Hif1b mRNA by qPCR in liver, pancreas, and heart of female control and FH1bKO mice. Mice were 6–8 weeks old. Data are shown as
mean ± SEM of four samples.
(D) Expression level ofHif1bmRNAby qPCR of stromovascular fraction (SVF) isolated from subcutaneous or perigonadal in control and FH1bKOmice. Mice were
6–8 weeks of age. Data are shown as mean ± SEM of four samples.
(E) Expression level of Arnt2 mRNA was compared using qPCR from samples described in Figure 1A.
*p < 0.05; **p < 0.01.
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Roles of Hif1b in Adipose Functionphenotypic abnormalities. Efficient and specific ablation ofHif1b
was confirmed by qPCR analysis. Hif1b mRNA was reduced
>90% in isolated subcutaneous and perigonadal adipocytes
from fat and brown adipose tissue from 6- to 8-week-old female
mice (Figure 1A). Western blot analysis of perigonadal isolated
adipocytes confirmed a corresponding decrease inHif1b protein
levels (Figure 1B). No changes in Hif1b mRNA levels were
observed in liver, pancreas, and heart (Figure 1C). In addition,
qPCR analysis of the stromovascular fraction, which contains
preadipocytes from subcutaneous, but not perigonadal, adipose
tissue showed a significant 40% reduction of Hif1bmRNA levels
(Figure 1D). No compensatory upregulation of the related gene
Arnt2 was noted (Figure 1E).
Ablation of Hif1b Attenuates Age- and Diet-Induced
Obesity
FH1bKO and littermate control floxed mice were fed a standard
chow diet (22% of calories as fat) or were subjected to high-fat
diet (HFD) (60% of calories as fat) starting at 6 weeks of age.
On a chow diet, both male and female FH1bKO exhibited
reduced weight gain compared to controls. By 10 months of492 Cell Metabolism 14, 491–503, October 5, 2011 ª2011 Elsevier Inage, male FH1bKO mice had a 24% reduction in weight gain,
(Figure 2A) and female FH1bKO mice were also 32% lighter
(Figure S1A available online). Male FH1bKO also exhibited an
16% reduction in weight gain when fed a HFD for 10 weeks
compared to controls. Similar results were observed in female
FH1bKO mice (Figure 2B). This weight gain difference was
observed as early as 8 weeks after being fed HFD (Figure S1A).
DEXA scans of chow-fed animals at 20 weeks of age showed
that male and female FH1bKO mice had 31% and 55% de-
creases of visceral fat mass and 20% and 33% decreases in
subcutaneous fat mass, respectively (Figure 2C). Histological
examination of the fat pads from 6- to 8-week-old animals
showed no changes in adipose tissue morphology. By 20 weeks
of age, there was reduced lipid droplet size in subcutaneous
and perigonadal adipocytes in FH1bKOmice, as well as reduced
triglyceride accumulation in the BAT (Figures 2D and S1B).
Median diameters of subcutaneous and perigonadal adipocytes
were decreased by 42% and 26%, respectively, in FH1bKO
animals relative to controls after 20 weeks of chow diet (Figures
2E, S1B, and S1C). Similar results were seen after 12 weeks of
HFD exposure, with an 24% decrease in median adipocytec.
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Figure 2. Ablation of Hif1b Attenuates Age- and Diet-Induced Obesity
(A) Body weight of female and male control and FH1bKO mice on chow diet. Data are shown as mean ± SEM of 5–6 animals/group.
(B) Body weight of female and male control and FH1bKO after 10 weeks of high-fat diet (HFD) starting at 6 weeks of age. Data are shown as mean ± SEM of
8–10 animals/group.
(C) Analysis of body composition by DEXA scan of control and FH1bKO at 5 months of age. Data are shown as mean ± SEM of 4–5 animals/group.
(D) Hematoxylin and eosin stained representative sections of fat pads and FH1bKO mice at 20 weeks of age on chow diet. Pictures were taken at 203.
(E) Median adipocyte size in adipocytes. Perigonadal and subcutaneous fat from 8 week chow-fed, 20 week chow-fed, and 12 week HFD (started at 6 weeks)
mice (n = 4/group) were hematoxylin and eosin stained. Five digital images (203) from nonoverlapping fields were taken from each slide (total of 20 fields per
group). Adipocyte diameters were calculated using Image J software. Values are median ± SEM of 4 animals.
(A–E) *p < 0.05.
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Roles of Hif1b in Adipose Functiondiameter in both white fat depots (Figures 2E and S1C). Consis-
tent with the reduced adipose tissue mass on HFD, FH1bKO
female and male mice had 41% and 34% decreases in leptin
levels, respectively, compared to controls. No changes in serum
adiponectin levels were observed (Figures S1D and S1E).
Together, these data show that FH1bKO mice are partially pro-
tected against age- and diet-induced obesity due to a decrease
in the ability of adipocytes to undergo hypertrophy.
Physiological Parameters in FH1bKO Mice
Young (8- to 10-week-old) FH1bKO mice had no abnormality
on any measured metabolic parameter, including fasting and
fed glucose, fasting and fed insulin levels, serum-free fatty acids,
orglucoseand insulin tolerance tests (TableS1;FigureS2A).How-
ever, with aging, metabolic parameters in FH1bKO mice differed
from controls. Old FH1bKO female and male mice had improved
glucose tolerance, with 53% and 31% reductions of area under
the curveonglucose tolerance testing, respectively, as comparedCellto controls.OldmaleFH1bKOmicealsohad lower fastingglucose
levels (Table S1). Likewise, after HFD challenge, male and female
FH1bKO mice had a 33% reduction under the curve on glucose
tolerance testing as compared to controls (Table S1; Figure S2A).
The reduction in weight gain and attenuation of obesity-induced
glucose intolerance in the FH1bKO mice was not associated
with a change in insulin tolerance (Table S1).
Hif1b detection had no discernable effect on other metaboli-
cally important tissues. In the liver, there were no changes in lipid
accumulation, as assessed by oil red O staining and triglyceride
analysis, or histological changes between FH1bKO and control
mice, even after HFD exposure (Figures S2B and S2C). Addition-
ally, western blot analysis of liver extracts showed no changes in
phosphorylation of IRS-1, Akt, or MAP kinase in response to
insulin, suggesting no major changes in insulin sensitivity in the
liver of FH1bKO mice (Figure S2D). Finally, islet function, as as-
sessed by glucose-stimulated insulin secretion, was not affected
in FH1bKO mice (Figure S3E).Metabolism 14, 491–503, October 5, 2011 ª2011 Elsevier Inc. 493
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Roles of Hif1b in Adipose FunctionTo better understand the basis for differences in weight gain
and fat mass, indirect calorimetry was performed on young
FH1bKO and control mice. No differences were observed
when animal had been fed with chow diet. However, after
10 weeks of HFD feeding, FH1bKO had a significant 11%–
15% increase in average oxygen consumption during both the
light phase (8508 ± 370 in FH1bKO versus 7417 ± 398 ml/kg
lean mass/hr, p < 0.05) and dark phase of the diurnal cycle
(9365 ± 416 versus 8476 ± 408 ml/kg lean mass/hr, p < 0.05)
(Table S2). In addition, FH1bKO consumed a similar amount of
calories and had comparable levels of activity as controls.
Together, these data suggest that the decreased weight gain
exhibited by FH1bKO mice was due to increased energy
expenditure.
Ablation of Hif1b Does Not Affect Fibrosis
and Macrophage Infiltration
Overexpression ofHif1a has been reported to increase fibrosis in
adipocytes (Halberg et al., 2009). In control mice, expression of
known markers of fibrosis mLox and Col1a1 were increased
>50% and 200%, respectively, in the subcutaneous fat after
12 weeks of HFD, and Col6a1 expression was increased by
> 80% in perigonadal fat (Figures S1F–S1H). Similar increases
in markers of fibrosis were observed in the FH1bKOmouse, indi-
cating that these effects occurred independently of Hif signaling.
Determination of the expression levels of inflammation
markers in adipose tissue revealed a significant increase in
proinflammatory cytokines, tumor necrosis factor a (Tnfa), and
macrophage chemo-attractant protein-1 (Mcp1) in both subcu-
taneous and perigonadal fat of control mice after HFD exposure
(Figures S1I and S1J).Mcp1 was also increased in the brown fat
of control mice on HFD. Likewise, expression of macrophage
marker CD68 was significantly increased in the subcutaneous
and perigonadal fat pads of control mice, and interleukin-6
(Il-6) was significantly increased in the subcutaneous fat of
control mice on HFD (Figures S1K and S1L). Immunohistochem-
ical staining of the macrophage marker F4/80 in control mice
showed a marked increase after HFD exposure. All of these
markers of inflammation and macrophage infiltration showed
almost identical increases in the fat depots of FH1bKO mice
(Figures S1I–S1M). Therefore, although Hif1b ablation leads to
decreased adipose cell size, induction of makers of fibrosis
and macrophage infiltration, classically observed in adipose
tissue with obesity, were not reduced in FH1bKOmice after chal-
lenge with a HFD.
Hif1b Ablation Decreases Glucose Uptake
The decreased adipocyte size observed in FH1bKO mice could
be the result of increased lipolysis, decreased lipogenesis,
and/or a defect in adipocyte differentiation. qPCR analysis
from subcutaneous and perigonadal fat of FH1bKO and litter-
mate control animals revealed no significant differences in the
mRNA levels of regulators and markers of adipogenesis,
including Cebpb, Cebpd, Pparg, FoxO1, and aP2 (Figures S3A
and S3B), suggesting that Hif1b ablation does not impair adipo-
cyte differentiation. Additionally, no differences in basal- or
isoproterenol-stimulated lipolysis were observed (Figure S3G).
However, both basal- and insulin-stimulated lipogenesis rates
were markedly reduced in isolated subcutaneous (60%) and494 Cell Metabolism 14, 491–503, October 5, 2011 ª2011 Elsevier Inperigonadal (80%) adipocytes from male FH1bKO mice
(Figure 3A). Likewise, in subcutaneous fat, uptake of [H3] 2-
deoxyglucose was reduced by > 40% in the basal state and
by 19%–40% in the insulin-stimulated state in FH1bKO mice
compared to controls (Figure 3B). This reduction was even
greater in perigonadal adipocytes, with an 86% decrease in
basal glucose uptake and 52%–78% decreases in insulin-stim-
ulated glucose uptake over the concentration range of 0.1 nM
to 100 nM insulin (Figure 3B).
In agreement with these defects in adipocyte glucose uptake
and lipogenesis, gene expression levels of the glucose trans-
porters Glut4 and Glut1 were reduced by > 50% and 24%,
respectively, in both perigonadal and subcutaneous fat of 6- to
8-week-old FH1bKO mice (Figure 3C). Thus, ablation of Hif1b
leads to decreased levels of glucose transport proteins, which
results in decreased glucose transport and, subsequently,
decreased lipogenesis.
qPCR analysis of the key lipogenic genes, including sterol-
regulatory-element-binding protein 1c (Srebp1C), acetyl-CoA
carboxylase (Acc1), and fatty acid synthase (Fas) in fat of
6-week-old FH1bKO males, showed no changes in expression
compared with controls (Figures S3C and S3D). After exposure
to HFD for 12 weeks, qPCR analysis revealed significantly lower
levels of Srebp1C, Acc1, Fas, and stearoyl-coenzyme A desatur-
ase 1 (Scd1) mRNA in the fat depots of FH1bKO mice (Figures
S3E and S3F).
Knockdown of Hif1b Reduces Glucose Uptake
To further investigate the mechanisms underlying the effects of
Hif1b in adipocytes, we utilized shRNA lentiviruses directed
against Hif1b to create two independent, stable 3T3-L1 knock-
down cell lines, shHif1b-1 and shHif1b-2, with 87% and 93%
reductions in Hif1b expression (Figure 4A). This decrease was
specific; the highly homologous Arnt2 was decreased by only
9% and 41% in these two cell lines, respectively (Figure 4A).
Western blot analysis showed no detectible Hif1b protein levels
in either shHif1b cell lines (Figure 4B). These shHif1b 3T3-L1
adipocyte cell lines displayed no difference in lipid accumulation,
as visualized by oil red O staining or triglyceride quantitation
(Figures 4C and S4A). No changes in the expression of the major
regulators and markers of adipose differentiation, including
Pparg, Cebpa, Cebpb, Cebpd, Foxo1, and aP2, were observed
(Figure S4B). Thus, knockdown of Hif1b does not affect adipo-
cyte differentiation.
However, basal- and insulin-stimulated uptake of 2-deoxyglu-
cose were decreased by 20%–30% in both shHif1b-1 and
shHif1b-2 adipocytes compared to controls (Figure 4D). This
correlated with 28% and 32% decreases in Glut1 and Glut4
mRNA levels in shHif1b-1 cells, respectively, and 45% and
21% decreases in shHif1b-2 cells, respectively, under normoxic
conditions (Figures 4E and 4F).
These shHif1b knockout cells showed altered responses to
hypoxia and the hypoxia mimetic CoCl2. Thus, in control cells,
Glut1 expression was increased 7-fold by hypoxia (16 hr at
0.1% O2) and 3-fold by following treatment with CoCl2 (200 mM
for 16 hr), whereas in shHif1b cells, the induction of Glut1 was
blunted by 47%–60% (Figure 4E). In these cells, western blot
analysis demonstrated that CoCl2 was also sufficient to strongly
increase Hif1a protein (Figure S4D). Western blot analysisc.
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Figure 3. FH1bKO Adipocytes Display Defects in Lipogenesis, Glucose Uptake, and Glucose Transporter Expression
(A) [14C] D-glucose incorporation into lipids in subcutaneous and perigonadal adipocytes isolated from control and FH1bKO animals at 12 weeks of age. Data are
represented as 14C counts and normalized to lipid content. Data are shown as mean ± SEM of 4 animals/group and are representative of two independent
experiments. *p < 0.05; **p < 0.01.
(B) [3H] 2-deoxyglucose uptake into subcutaneous and perigonadal adipocytes isolated from control and FH1bKO animals at 15 weeks of age. Data are rep-
resented as 3H counts and normalized to lipid content. Data are mean ± SEM of 4 animals/group. The entire experiment was repeated twice. *p < 0.05.
(C) Expression levels of Glut1 and Glut4 mRNA were compared using qPCR between subcutaneous and perigonadal in male control and FH1bKO mice. Mice
were 6–8 weeks old. Data are mean ± SEM of four samples.
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Roles of Hif1b in Adipose Functionconfirmed the reduced Glut1 and Glut4 levels in shHif1b adipo-
cytes under normoxic conditions (Figure 4G).Glut4mRNA levels
were not significantly changed by hypoxia or CoCl2 treatment in
either shHif1b or control cells, and expression levels remain
significantly different between shHif1b and control adipocytes
after treatment with CoCl2 (Figure 4F).
As previously reported, osmotic shock can stimulate Glut4
translocation in 3T3-L1 adipocytes in an insulin-independent
manner (Chen et al., 1997). shHif1b cells exhibited a decrease
of 25% in 2-deoxygucose uptake when subjected to osmotic
shock with 600mMsorbitol (Figure S4C). By contrast, no change
in fatty acid uptake, measured by 14C-labeled palmitic acid
incorporation, was observed in shHif1b cells (Figure S4E).
Thus, the decreased levels of glucose transport proteins that
result in decreases in glucose transport are cell-autonomous
effects caused by the ablation of Hif1b.
Hif1b Ablation Decreases Vascular Permeability
Many tissues have been shown to undergo remodeling of
vascular structure in response to hypoxia (Kaluz et al., 2008).
To determine whether ablation of Hif1b in adipocytes would
cause a difference in vascular structure in fat, we visualized
blood vessels using CD31 immunofluorescence in whole-mount
fat pads from FH1bKO and control mice. Vascular density within
individual fat pads exhibited heterogeneity, but there were noCellsignificant differences in blood vessel density in either subcuta-
neous or perigonadal fat pads of young or HFD-exposed
FH1bKO mice compared to control mice (Figures 5A and S5A).
Capillary density at 8 weeks of age, as assessed by immunoflu-
orescence for GSL I-isolectin, was also unchanged in FH1bKO
males (Figures S5C and S5D). After HFD, capillary density was
increased by 31% in the subcutaneous fat and by several fold
in brown adipose tissue of FH1bKO males (Figures 5B and
S5E). However, these increases are most likely due to the differ-
ence in adipose cell size, which leads to an apparent difference
in cellular density in microscopic fields between controls and
FH1bKO.
Staining with pimonidazole to identify hypoxic regions in fat
pads from 8-week-old mice showed similar results. Under
chow diet, young FH1bKO and control animals had very little
pimonidazole staining in either the subcutaneous or perigona-
dal adipose tissue. After HFD, areas of scattered pimonida-
zole positivity were found in fat pads of both FH1bKO and
control mice with no apparent differences between genotypes
(Figure S5B).
Eight-week-old FH1bKO mice exhibited no changes in body
weight or fat pad weight compared to controls. However, at
this age, extravasation of Evans Blue dye into the subcutaneous
and perigonadal fat pads revealed an 40% reduction in
vascular permeability in adipose tissue of FH1bKOmice (FiguresMetabolism 14, 491–503, October 5, 2011 ª2011 Elsevier Inc. 495
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Figure 4. shRNA Knockdown of Hif1b Decreases Glucose Uptake
(A) Expression level of Hif1b and Arnt2mRNA was compared using qPCR between 3T3-L1 preadipocytes stably transfected with shHif1b-1 and shHif1b-2. Data
are normalized by relative expression ofHif1b and Arnt2mRNA in shGFP cells and are shown asmean ± SEM of triplicate samples, repeated five times. * p < 0.05
in all panels.
(B) Western blot of Hif1b from protein extracts from 3T3-L1 preadipocytes stably transfected with shHif1b-1, shHif1b-2, and shGFP cells. Actin was used as
a loading control.
(C) Quantification of oil red-O staining in shHif1b-1, shHif1b-2, and shGFP adipocytes. Data are shown as mean ± SEM of triplicate samples repeated twice.
Asterisks indicate a significant difference (p < 0.05).
(D) Glucose uptake, as assessed by acute uptake of 3H-labeled 2-deoxyglucose into shHif1b-1, shHif1b-2, and shGFP stably transfected adipocytes. Data are
represented as 3H count normalized to protein content and are shown as mean ± SEM of triplicate samples repeated three times.
(E and F) Expression ofGlut1 andGlut4 asmeasured by qPCR in cells with stable knockdowns ofHif1b-1,Hif1b-2, and shGFP. After 8 days of differentiation, cells
were subjected to normoxia, hypoxia (0.1%O2 for 16 hr), or 200 nMCoCl2 for 16 hr. Data are shown asmean ± SEMof triplicate samples and repeated three times.
(G) Western blot of Glut1 and Glut4 from protein extracts from shHif1b-2 and shGFP 3T3-L1 adipocytes after 8 days of differentiation. Actin was used as a loading
control.
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Roles of Hif1b in Adipose Function5C and S5F). Thus, although FH1bKOmice do not have reduced
vasculature, they do have a significant reduction in vascular
permeability in fat.
Changes in vascular permeability during hypoxia are primarily
mediated by vascular endothelial growth factor (Vegf). In all
fat depots of FH1bKO mice, Vegf mRNA expression was
decreased by 40%, and this was confirmed by a corresponding
decrease in Vegf protein level in isolated adipocytes from peri-
gonadal fat (Figure 5D). Likewise, Vegf mRNA levels were
decreased by 37% in both shHif1b knockdown cell lines under
normoxic conditions (Figure 5E). In both control and knock-
down cell lines, hypoxia led to a 3-fold increase in Vegf
mRNA, although Vegf expression remained proportionately
lower in the shHif1b cells. These results were confirmed by
western blot analysis of Vegf protein from whole-cell lysates
and surrounding tissue culture media (Figure 5F), mirroring the
in vivo finding that loss of Hif1b leads to a decrease in Vegf
and vascular permeability.496 Cell Metabolism 14, 491–503, October 5, 2011 ª2011 Elsevier InRole of Hif1b in Hypoxia Sensing
To assess the consequences of Hif1b ablation on cellular respi-
ration, we used a Seahorse extracellular flux analyzer to deter-
mine basal andmaximal mitochondrial respiration, ATP turnover,
and nonmitochondrial respiration by measuring oxygen
consumption rate (OCR) of differentiated control and Hif1b
knockdown 3T3-L1 cells. Under normoxic conditions, no signif-
icant differences were seen in the bioenergetics profiles of
control and shHif1b 3T3-L1 adipocytes (Figure 6A). Pretreatment
of the control cells for 16 hr with the hypoxia mimetic CoCl2
(200 mM) led to an 33% reduction of basal respiration and
a striking 67% reduction in maximal respiratory capacity. By
comparison, shHif1b 3T3-L1 adipocytes showed no decrease
in basal or maximal respiration after CoCl2 treatment (Figures
6A–6C). No significant differences were found between control
and knockdown cells in the proton leak or nonmitochondrial
respiration. To investigate the molecular mechanisms that are
changed in hypoxia sensing in the shHif1b cells, we performedc.
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Figure 5. Hif1b Ablation Decreases Vascular Permeability and Vegf Expression
(A) (Left) CD31 immunohistochemistry on whole mounts of subcutaneous fat from control and FH1bKO male mice at 8 weeks of age. The photograph was taken
at 1003. (Right) CD31 immunohistochemistry on whole mounts of subcutaneous fat from control and FH1bKO male mice after 12 weeks of exposure to HFD.
(B) Quantitation of capillary density in the perigonadal and subcutaneous fat pads after 12 weeks on HFD, starting at 6 weeks of age (n = 4/group). Slides were
stained for GSL I-isolectin B4. Capillaries were counted in digital images from control and FH1bKOmales (n = 4). Three digital images (203) from nonoverlapping
fields were taken from each slide (total 12 fields per group). Data are shown as mean ± SEM of three samples. *p < 0.05.
(C) Quantitation of the amount of Evan’s blue in fat pads 10 min after intracardiac injection and perfusion into control and FH1bKO male mice at 8 weeks of age.
Data are normalized by gram of lipid from fat pads and are shown as mean ± SEM of three samples. Asterisks indicate a significant difference in all panels
(p < 0.05).
(D) Levels of Vegf mRNA were compared using qPCR between adipocytes isolated from the subcutaneous fat (SCF) and perigonadal fat (PGF). Mice were
6–8 weeks old. Data are shown asmean ± SEM of five samples. *p < 0.05. Western blot of Vegf from isolated PGF adipocytes of female control and FH1bKOmice
at 12 weeks of age. Western blot for actin is a loading control. Data are representative of four samples.
(E) mRNA was isolated from shHif1b-1, shHif1b-2, and shGFP stably transfected adipocytes after 8 days of differentiation and subjected to normoxia, hypoxia
(0.1% O2 for 16 hr), or 200 nM CoCl2 for 16 hr. Expression of Vegf was measured by qPCR. Data are shown as mean ± SEM of triplicate samples and repeated
three times.
(F) Western blot of Vegf from protein extracts from 3T3-L1 adipocytes stably transfected with shHif1b-1, shHif1b-2, and shGFP adipocytes or media secreted
by shHif1b-1, shHif1b-2, and shGFP adipocytes after 8 days of differentiation. Actin was used as a loading control.
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Roles of Hif1b in Adipose FunctionqPCR analysis on genes encoding mitochondrial proteins
involved in oxidative phosphorylation. Numerous genes were
unchanged by Hif1b ablation either in normoxic conditions or
after pretreatment with CoCl2 (Figures S7A and S7B). Likewise,
under normoxic conditions, no changes were observed in cyto-
chrome c1 (Cytc1) or cytochrome c oxidase, subunit IV, isoform
2 (Cox4.2), both components of complex III. However, whereas
in control adipocytes, hypoxia induced a 32% and 66%
decrease in Cytc1 and Cox4.2 expression, respectively, there
was no change in Cytc1 expression, and the repression of
Cox4.2 was reduced to 44% in shHif1b cells (Figure 6D). Like-
wise, in control adipocytes, treatment with CoCl2 produced
a 20% decrease in Cytc1 expression and a 44% decrease in
Cox4.2 expression, and these reductions were lost in the shHif1b
adipocytes (Figure 6D). Thus, Hif1b is critical for the transitionCellinto the hypoxic state, and this involves repression of compo-
nents of mitochondrial complex III.
The Roles of Hif1b in Adipocytes Are Partially Mediated
by Hif1a
The data above show that ablation of Hif1b in adipocytes in vivo
and in vitro leads to changes in the expression of glucose trans-
porters, Vegf, and components of the mitochondrial electron
transport chain. BecauseHif1b acts as an obligate heterodimeric
partner for all Hif-a isoforms, as well as Ahr, we created stable
knockdown 3T3-L1 cell lines for the two dominant forms of
Hif-a (1 and 2) and Ahr to elucidate which of these factors might
act with Hif1b to regulate these effects. qPCR analysis of differ-
entiated shHif1a, shHif2a, shAhr, and shSCR (control) adipo-
cytes demonstrated specific knockdowns of each transcriptionMetabolism 14, 491–503, October 5, 2011 ª2011 Elsevier Inc. 497
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Figure 6. Hif1b shRNA Knockdown Increases Respiratory Capacity during CoCl2 Treatment
(A) Bioenergetics profile, as measured by oxygen consumption rate with a Seahorse X24 extracellular flux analyzer, of shHif1b-1, shHif1b-2, and shGFP 3T3-L1
adipocytes under normoxic conditions.
(B) Bioenergetics profile, as measured by oxygen consumption rate with a Seahorse X24 extracellular flux analyzer, of shHif1b-1, shHif1b-2, and shGFP 3T3-L1
adipocytes after pretreatment with CoCl2.
(C) Basal respiration and maximal respiratory capacity of shHif1b-1, shHif1b-2, and shGFP 3T3-L1 adipocytes was determined by calculating the area under the
curve (AUC) in the basal phase and after uncoupling with FCCP. Values are means ± SEM of 6–7 replicates of three separate experiments. Asterisks indicate
a significant difference compared to shGFP control in all panels. p < 0.05.
(D) mRNA was isolated from shHif1b-1, shHif1b-2, and shGFP stably transfected adipocytes after 8 days of differentiation and subjected to normoxia, hypoxia
(0.1%O2 for 16 hr), or 200 nMCoCl2 for 16 hr. Expression ofCytc1 andCox4.2wasmeasured by qPCR. Data are shown asmean ± SEM of triplicate samples and
repeated three times.
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did lead to a 3.5-fold compensatory increase in Hif2a levels.
Western blot analysis of cell lines under hypoxic conditions
confirmed ablation of Hif1a and Ahr in shHif1a and shAhr cell
lines, respectively (Figure S6B).
shSCR, shHif1a, shHif2a, and shAhr 3T3-L1 adipocytes,
differentiated using a standard induction protocol including
10 nM rosiglitizone, displayed no difference in lipid accumulation
as visualized by oil red O staining (Figure 7A) or quantitation of
cellular triglycerides (Figure S6D). However, there was a 50%
reduction inCebpa,Cebpb, and aP2, but no differences inPparg,
in differentiated shHif1a adipocytes. No changes in these adipo-
cyte differentiation markers were found in differentiated shHif2a
adipocytes, and shAhr cell lines had a significant 2-fold in-
crease in Cebpa and aP2 compared to controls (Figure S6C).
shHif1a adipocytes also had a defect in glucose uptake, with
a 76% decrease in basal glucose uptake and a 55%–88%498 Cell Metabolism 14, 491–503, October 5, 2011 ª2011 Elsevier Indecrease in insulin-stimulated glucose uptake (Figure 7B) that
was similar to the decrease following Hif1b ablation (Figures
3B and 4D). By contrast, insulin-stimulated glucose uptake
was unchanged in the shAhr adipocytes and was increased
3-fold in shHif2a adipocytes (Figure 7B). Interestingly, neither
Glut4 nor Vegf expression levels were significantly changed
in any of the knockdown cell lines (Figure 7C). As with shHif1a
cells, Glut1 expression in the shHif1a cell line was decreased
by 67%–75% in all conditions. Likewise, the repression of
Cytc1 during hypoxia and CoCl2 treatment that was lost
upon Hif1b knockdown was also absent upon knockdown of
Hif1a but was normal in Hif2a or Ahr cells (Figure 7C). On
the other hand, Cox4.2 expression was efficiently repressed
by both hypoxia and CoCl2 treatment in all knockdown cell
lines. These data demonstrate that signaling through Hif1a is
critical for some, but not all, processes controlled by Hif1b in
adipocytes.c.
AB
C
Figure 7. Ablation of Hif1a Recapitulates a Subset of the Effects of Hif1b Ablation
(A) Triglyceride accumulation after 8 days of differentiation was visualized by oil red O staining in shHif1a, shHif2a, shAhr, and shScr (control) adipocytes after
8 days of differentiation.
(B) 3H-labeled 2-deoxyglucose uptake into shHif1a, shHif2a, shAhr, and shScr stably transfected adipocytes after 8 days of differentiation. Data are represented
as 3H counts normalized to protein content. Data are shown asmean ± SEM of four samples and repeated twice. Values aremeans ± SEM. *p < 0.05 compared to
shSCR control with the same treatment in all panels (p < 0.05).
(C) mRNA was isolated from shHif1a, shHif2a, shAhr, and shScr stably transfected adipocytes after 8 days of differentiation and subjected to normoxia, hypoxia
(0.1% O2 for 16 hr), or 200 nM CoCl2 for 16 hr. Expression of Glut1, Glut4, Vegf, Cytc1, and Cox4.2 was measured by qPCR. Data are shown as mean ± SEM of
four samples and repeated twice.
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In obesity, as adipose tissue expands, the cells further from
vessels become hypoxic, and this contributes to adipose tissue
dysfunction (Trayhurn et al., 2008). Hypoxia in adipocytes, which
was demonstrated in several rodent models of obesity (Rausch
et al., 2008; Ye et al., 2007; Hosogai et al., 2007), is also present
in humans, as shown by multiple lines of evidence. First, obesity
leads to hypoperfusion of adipose tissue (Stuart et al., 2009).
Second, Hif-1a expression is increased in the adipose tissue of
obese individuals, and this can be reversed by weight loss (Can-
cello et al., 2005). Finally, all Hif-a subunits have been shown to
have roles in adipocyte differentiation and function (Halberg
et al., 2009; Regazzetti et al., 2009; Shimba et al., 2004; Hata-
naka et al., 2009).However, understanding the roles of individual
Hif proteins is complicated by the ability of different Hif-a
subunits to at least partially compensate for one another, as illus-
trated by the partially overlapping target gene sets of Hif1a
and Hif2a (Hu et al., 2003). Therefore, in the present study, weCellutilized a fat-specific ablation of the obligate heterodimeric
partner for all Hif-a subunits, Hif1b, to explore the role of the
integrated Hif-signaling system in adipose tissue.
We find that both male and female mice lacking Hif1b in fat
(FH1bKO mice) are protected against age- and diet-induced
obesity. Indirect calorimetry revealed that this is associated
with increased energy expenditure. FH1bKO mice also exhibit
striking protection against obesity-related glucose intolerance
and insulin resistance. Interestingly, despite the fact that they
are leaner, the inflammatory and fibrotic response in fat after
HFD is unchanged in FH1bKO mice. Thus, deletion of Hif1b in
adipocytes protects against some, but not all, of the changes
induced by HFD.
Ablation of Hif1b in fat protects against obesity by reducing
adipocyte cell size. The primary sources of triglyceride
synthesis, which determines adipocyte cell size, are de novo
lipogenesis and fatty acid uptake from plasma. Based on cellular
models, uptake of radiolabeled C14 palmitate is unchanged by
loss of Hif1b. Thus, the primary defect leading to a reduction inMetabolism 14, 491–503, October 5, 2011 ª2011 Elsevier Inc. 499
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lipogenesis. Both in vivo and in vitro, loss of Hif1b causes
a reduction in the expression of the Glut1 and Glut4 glucose
transporters. Glut1 is a well-known target of the hypoxia
response and has been shown to be dependent on signaling
by theHif1a/Hif1b complex (Hayashi et al., 2004). In 3T3-L1cells,
Hif 2a can also regulate Glut1 and Glut4 (Shimba et al., 2004). In
FH1bKO adipocytes and Hif1b knockdown 3T3-L1 adipocytes,
this reduction in glucose transporters leads to decreased
glucose uptake and a reduction of de novo lipogenesis, resulting
in decreased adipocyte cell size.
It is likely that the 50% reduction of glucose transporters
observed when Hif1b is ablated plays an important role in
reduced glucose uptake and smaller adipocytes in the FH1bKO
mice. Ablation ofGlut4 alone in adipose tissue results in amarked
decrease in insulin-stimulated glucose uptake, leading to
glucose intolerance and insulin resistance, but without change
in adipose cell size (Abel et al., 2001). By contrast, whole-body
haploinsuffiency of Glut1 leads to defects in development
(Wang et al., 2006) and an altered cellular response to hypoxic
stress (Heilig et al., 2003). Stable knockdown of Glut4 in 3T3-
L1 adipocytes leads to decreased lipid accumulation, and
the knockdown of Glut1 and Glut4 in combination leads to an
almost complete absence of basal and insulin-mediated glu-
cose uptake (Liao et al., 2006).
In addition to the reduced glucose uptake, there is a significant
downregulation in expression of key lipogenic enzymes in
FH1bKO fat during HFD exposure. To what extent this is a cause
or effect of reduced adipose mass is difficult to assess, as
previous studies have demonstrated that smaller adipocytes
have lower levels of lipogenic gene expression (Blu¨her et al.,
2004). Therefore, it is likely that Hif1b ablation causes a primary
defect in glucose uptake that, in turn, leads to reduced adipocyte
cell size and reduced lipogenic gene expression because in 6-
week-old FH1bKO mice, there is no decrease in fat mass and
lipogenic gene expression in adipose tissue is normal.
In general, the transcription of Hif-1 target genes serves to
alter cellular responses and the local microenvironment to
alleviate the hypoxia stress. A key component of this response
is to promote angiogenesis through increased expression of
Vegf, the Hif-1 target gene (Forsythe et al., 1996). Ablation of
Hif1b both in vivo and in vitro leads to a significant decrease
of Vegf mRNA and protein. This reduction in Vegf does not
lead to a reduction of vessel or capillary density in the fat in either
chow or HFD-challenged FH1bKO mice. However, prior to any
change in body or fat mass, the reduction in Vegf leads to
a significantly decreased vascular permeability, as assessed
by Evans Blue extravasation of dye. Additionally, increased
vascular permeability has been shown to be central to the
adipose tissue expansion induced by thiazolidinedione treat-
ment (Sotiropoulos et al., 2006). On the other hand, previous
studies have shown that increases in adipocyte mass can be
altered by angiogenesis inhibitors (Rupnick et al., 2002). Like-
wise, blocking Vegf action by treating mice with antibodies to
the Vegf receptor has been shown to reduce weight gain during
diet-induced obesity (Tam et al., 2009). Thus, the changes that
we observe in Vegf and vascular permeability could contribute
to the reduction of adipocyte hypertrophy in the FH1bKO
animals.500 Cell Metabolism 14, 491–503, October 5, 2011 ª2011 Elsevier InThere is a well-established link between mitochondrial activity
and hypoxia. Previous studies have demonstrated that reactive
oxygen species produced by the mitochondria (mtROS) are
essential for oxygen sensing and Hif1a/Hif2a stabilization during
hypoxia. In particular, mtROS generated from complex III has
been shown to be necessary for regulating Hif1a and Hif2a
(Guzy et al., 2005; Bell et al., 2007), and loss of the complex III
protein, cytochrome c, impairs cellular oxygen sensing and
Hif1a activation in response to hypoxia (Mansfield et al., 2005).
In this study, we find that Hif1b is necessary for the downregula-
tion of Cytc1, which occurs during hypoxia and after treatment
with the hypoxia mimetic CoCl2. Interestingly, adipose tissue
from mice with fat-specific knockout of the insulin receptor
(FIRKO mice) exhibits lower levels of Hif1a and higher levels of
Cytc1 (Katic et al., 2007). It is likely that the smaller adipocytes
present in the FIRKO mice have lower levels of hypoxia and
thus retain higher levels of mitochondrial activity. The results
presented here further elucidate that relationship by demon-
strating the coordination of these hypoxia and mitochondrial
activity in an entirely different model system.
In the lung and liver, Hif1a has been shown to regulate Cox4.1
and Cox4.2 expression (Fukuda et al., 2007). Reduced oxygen
availability leads to increased transcription of Cox4.2 and Lon,
the mitochondrial protease required for Cox4.1 degradation
and optimization of respiratory efficiency. In contrast to these
findings, in adipocytes from normal mice, there is a decrease
in expression of Cox4.2 after exposure to hypoxia or treatment
with CoCl2 treatment and no change in Cox4.1 expression,
whereas expression of Lon is increased by hypoxia, but not
CoCl2. In adipocytes, this repression of Cox4.2, but not the
increased expression of Lon, is dependent on the presence of
Hif1b (Figures S7C and S7D). Thus, the regulation of Cox4.1
and Cox4.2 expression in response to hypoxia is different in
adipocytes than in the liver or lung.
The relationship of these changes in gene expression to other
markers of hypoxic stress is complex. Immunohistochemical
staining for pimonidazole adducts, which mark hypoxic areas,
shows that hypoxia within the fat pads of young control and
FH1bKO animals is relatively low. However, in HFD-induced
obesity, hypoxic regions can be found scattered through both
the subcutaneous and perigonadal fat pads of control mice
and also can be found in FH1bKO mice despite their protection
from adipocytes hypertrophy and obesity. Levels of the proin-
flammatory cytokines Tnfa and Mcp1, as well as macrophage
infiltration, are increased by HFD in control mice, as expected;
again, this was unchanged in FH1bKO mice, despite the smaller
adipocytes and fat pad weight. Additionally, consistent with
previous studies in the ob/ob mouse (Halberg et al., 2009), we
observed increased expression of numerous markers of fibrosis,
includingmLox,Col6a1, andCol1a1, after 12 weeks of HFD, and
these markers were unchanged by Hif1b ablation. Thus, despite
protection from adipocyte enlargement and obesity, FH1bKO
mice still exhibit evidence of increased fibrosis and inflammation
in response to HFD.
FH1bKOmice display normal brown fatmorphology on normal
and HFD but show increased capillary density compared to
controls after HFD exposure. This is in contrast to effects of
adipose-specific expression of a dominant-negative Hif1a,
which results in decreases in mitochondrial content and vascularc.
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insulin resistance (Zhang et al., 2010). An important difference
between these two models is that ablation of Hif1b not only
inhibits Hif1a signaling, but also inhibits the actions of Hif2a
andAhr. This is in keeping with our findings that, in cultured cells,
Hif1a andHif2a have distinct roles in adipocyte biology. Ablation
of Hif1a reduces glucose uptake, whereas ablation of Hif2a
enhances glucose uptake. Interestingly, Hif2a is upregulated in
Hif1a knockout cells. These data suggest an important role for
Hif2a in adipocytes. Hif1b may also exert effects by partnering
with the aryl hydrocarbon receptor Ahr. Knockdown of Ahr in
3T3-L1 adipocytes leads to an increase in the differentiation
markers Cebpa and aP2, supporting previous experiments that
demonstrate that Ahr is a negative regulator of adipogenesis
that affects expression of Cebpa and, subsequently, aP2 (Alex-
ander et al., 1998; Shimba et al., 2001). Thus, attenuation of Ahr
activity by ablation ofHif1b in the adipose tissue of FH1bKOmay
lead to an enhanced differentiation capacity that rescues the
differentiation defect observed in the BAT of dominant-negative
Hif1a mice.
Both shHif1b and shHif1a adipocytes exhibit reduced expres-
sion of Glut1, reduced glucose uptake, and a lack of repression
of Cytc1 in response to hypoxia. However, other molecular
changes, including reduced Glut4 and Vegf expression, as well
as the loss of Cox4.2 repression observed in the shHif1b adipo-
cytes, are not observed after ablation of the interacting partners.
These data suggest that Hif1b alters signaling through other
pathways or that there is redundancy between these interacting
partners.
In conclusion, Hif1b (Arnt) plays a pivotal role in adipose
tissue by controlling glucose uptake, expression of Vegf, and
regulation of the hypoxia in a cell-autonomousmanner response.
The altered Vegf expression results in secondary cell, or nonau-
tonomous, changes in vascular permeability. Together, these
effects control adipose growth and triglyceride accumulation.
Thus, reducing Hif1b in adipose tissue limits the effects of
hypoxia on adipose tissue in the obese state and may represent
a therapeutic target for treatment of obesity.
EXPERIMENTAL PROCEDURES
Further details on many of the experimental methods, including the mainte-
nance of mice, metabolic analysis, glucose and palmitate uptake, lipogensis,
lipolysis, cell culture, cloning, histology, antibodies utilized, and the oxygen
consumption assays, can be found in the Supplemental Experimental
Procedures.
Animals and Diets
aP2-cre and Hif1b floxed animals have previously been described (Abel et al.,
2001; Tomita et al., 2000). Animal care and study protocols were approved by
the Animal Care Committee of the Joslin Diabetes Center.
Body Composition and Metabolic Analysis
Body composition was measured using a Lunar PIXImus2 densitometer
(GE Medical Systems). Adipocyte diameters from FH1bKO and control mice
at 6–8 weeks old, 20 weeks old, and after 12 weeks of HFD exposure were
calculated using Image J software. Activity was measured using the OPTO-
M3 sensor system (Comprehensive Laboratory Animal Monitoring System,
CLAMS; Columbus Instruments). Indirect calorimetry was measured on the
same mice using an open-circuit Oxymax system (Columbus Instruments).
Intraperitoneal glucose (2 g/kg weight) and insulin tolerance (1.25 unit/kg) tests
were performed after a 16 and 4 hr fast, respectively. Insulin, free fatty acids,Cellleptin, and adiponectin were measured by ELISA (Crystal Chem). Adipocyte
diameters were calculated using Image J software.
Analysis of Gene Expression
Total RNA was isolated using an RNeasy minikit (QIAGEN), and cDNA was
synthesized with the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). Gene expression was determined by RT-qPCR performed on
a ABI Prism 7900HT sequence.
Lentiviral Infection and 3T3-L1 Differentiation
Hif1b, Hif1a, Hif2a, and Ahr were stably knocked down in 3T3-L1 cells
by shRNA delivered by lentiviral infection and selected with puromycin. Differ-
entiation was induced by exposing the cells to 1 mM dexamethasone, 500 mM
isobutylmethylxanthine, and 100 nM insulin for 2 days. Except for the assess-
ment of differentiation capacity, the PPARg agonist 1 mM rosiglitazone was
added in all experiments. Cells were then grown for 6 days in 100 nM insulin.
Medium was replaced every other day.
Histology
Vascularity in the fat pads was determined by whole-mount CD31 immunoflu-
orescence and staining of GSL I-isolectin B4. For permeability analysis, Evans
blue dyewas administered by intracardiac injection, followed by perfusionwith
phosphate-buffered saline. Lipids from liver samples and differentiated culture
plates were visualized and quantified by oil red O staining.
Oxygen Consumption Assay
Oxygen consumption was measured using the XF24 Extracellular Flux
Analyzer from Seahorse Bioscience. A bioenergetics profile was determined
by sequential injections of oligomycin, FCCP, and rotenone.
Statistics
All differences were analyzed by the Student’s t test. Results were considered
significant if p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
doi:10.1016/j.cmet.2011.08.006.
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